These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 36008805)

  • 1. METTL3 promotes non-small cell lung cancer (NSCLC) cell proliferation and colony formation in a m6A-YTHDF1 dependent way.
    Dou X; Wang Z; Lu W; Miao L; Zhao Y
    BMC Pulm Med; 2022 Aug; 22(1):324. PubMed ID: 36008805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. METTL3/IGF2BP1 influences the development of non-small-cell lung cancer by mediating m6A methylation modification of TRPV1.
    Bai W; Xiao G; Xie G; Chen Z; Xu X; Zeng J; Xie J
    Thorac Cancer; 2024 Sep; 15(26):1871-1881. PubMed ID: 39090761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-associated fibroblasts-derived exosomal METTL3 promotes the proliferation, invasion, stemness and glutaminolysis in non-small cell lung cancer cells by eliciting SLC7A5 m6A modification.
    Fan Y; Yu Y
    Hum Cell; 2024 Jul; 37(4):1120-1131. PubMed ID: 38625505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-MYC/METTL3/LINC01006 positive feedback loop promotes migration, invasion and proliferation of non-small cell lung cancer.
    Liu C; Ren Q; Deng J; Wang S; Ren L
    Biomed J; 2024 Aug; 47(4):100664. PubMed ID: 37774794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting METTL3 enhances the chemosensitivity of non-small cell lung cancer cells by decreasing ABCC2 expression in an m
    Zhang R; Chen P; Wang Y; Zeng Z; Yang H; Li M; Liu X; Yu W; Hou P
    Int J Biol Sci; 2024; 20(12):4750-4766. PubMed ID: 39309428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. METTL3‑mediated m6A modification of Bcl‑2 mRNA promotes non‑small cell lung cancer progression.
    Zhang Y; Liu S; Zhao T; Dang C
    Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34132367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation recognition protein YTH N6-methyladenosine RNA binding protein 1 (YTHDF1) regulates the proliferation, migration and invasion of osteosarcoma by regulating m6A level of CCR4-NOT transcription complex subunit 7 (CNOT7).
    Wei K; Gao Y; Wang B; Qu YX
    Bioengineered; 2022 Mar; 13(3):5236-5250. PubMed ID: 35156522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YTHDF1 Promotes Bladder Cancer Cell Proliferation via the METTL3/YTHDF1-RPN2-PI3K/AKT/mTOR Axis.
    Zhu J; Tong H; Sun Y; Li T; Yang G; He W
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. m
    Jin D; Guo J; Wu Y; Du J; Yang L; Wang X; Di W; Hu B; An J; Kong L; Pan L; Su G
    J Hematol Oncol; 2019 Dec; 12(1):135. PubMed ID: 31818312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methyltransferase 3, N6-adenosine-methyltransferase complex catalytic subunit-induced long intergenic non-protein coding RNA 1833 N6-methyladenosine methylation promotes the non-small cell lung cancer progression via regulating heterogeneous nuclear ribonucleoprotein A2/B1 expression.
    Li D; Fu Z; Dong C; Song Y
    Bioengineered; 2022 Apr; 13(4):10493-10503. PubMed ID: 35441574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis.
    Zhang HM; Qi FF; Wang J; Duan YY; Zhao LL; Wang YD; Zhang TC; Liao XH
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. m6A-mediated lncRNA NEAT1 plays an oncogenic role in non-small cell lung cancer by upregulating the HMGA1 expression through binding miR-361-3p.
    Qi L; Yin Y; Sun M
    Genes Genomics; 2023 Dec; 45(12):1537-1547. PubMed ID: 37688756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. METTL3-mediated the m6A modification of SF3B4 facilitates the development of non-small cell lung cancer by enhancing LSM4 expression.
    He G; Gu K; Wei J; Zhang J
    Thorac Cancer; 2024 Apr; 15(11):919-928. PubMed ID: 38462740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mettl3-m6A-YTHDF1 axis promotion of mitochondrial dysfunction in metabolic dysfunction-associated steatotic liver disease.
    Wang S; Zhang W; Wang Z; Liu Z; Yi X; Wu J
    Cell Signal; 2024 Sep; 121():111303. PubMed ID: 39019337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. METTL3 facilitates prostate cancer progression via inducing HOXC6 m6A modification and stabilizing its expression through IGF2BP2-dependent mechanisms.
    He P; Liu X; Yu G; Wang Y; Wang S; Liu J; An Y
    Mol Cell Biochem; 2024 Jul; 479(7):1707-1720. PubMed ID: 38822192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. METTL3-mediated m6A modification of STEAP2 mRNA inhibits papillary thyroid cancer progress by blocking the Hedgehog signaling pathway and epithelial-to-mesenchymal transition.
    Zhu Y; Peng X; Zhou Q; Tan L; Zhang C; Lin S; Long M
    Cell Death Dis; 2022 Apr; 13(4):358. PubMed ID: 35436987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. METTL3 promotes the malignancy of non-small cell lung cancer by N6-methyladenosine modifying SFRP2.
    Zhao S; Song P; Zhou G; Zhang D; Hu Y
    Cancer Gene Ther; 2023 Aug; 30(8):1094-1104. PubMed ID: 37106069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. METTL3 suppresses invasion of lung cancer via SH3BP5 m6A modification.
    Zhang B; Qian R; Li X
    Arch Biochem Biophys; 2024 Feb; 752():109876. PubMed ID: 38141906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner.
    Han J; Wang JZ; Yang X; Yu H; Zhou R; Lu HC; Yuan WB; Lu JC; Zhou ZJ; Lu Q; Wei JF; Yang H
    Mol Cancer; 2019 Jun; 18(1):110. PubMed ID: 31228940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pathological tissue expression pattern and clinical significance of m6A-regulatory genes in non-small cell lung cancer.
    Li Y; Zhang X; Cai J; Ren L; Liu B; Wu M; Lu W; Li R; Zhang C; Huang C; Tong J; Liu A; Zheng Y; Ren D; Guo Y; Huang Y
    J Gene Med; 2022 Feb; 24(2):e3397. PubMed ID: 34751492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.